Next month, hundreds of African infants will get an experimental vaccine against malaria in a medial trial that could foster a multibillion dollar collaboration of science, philanthropy and market
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/malaria-trial-yield-vaccines-finance-model
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/asian-wall-street-journal-hong-kong
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
